A Real World Study of Sacituzumab Govitecan

Exclusion Criteria

• •1. Pregnant or lactating women;
• •2. Those with acute or chronic infections, or those with other serious diseases at the same time, are judged by the researchers as unsuitable for this study;
• •3. Having suffered from other malignant tumors within 5 years (excluding the following situations: cured basal cell carcinoma of the skin, carcinoma in situ of the cervix, and papillary thyroid carcinoma; A second primary cancer that has been completely cured and has no recurrence within five years; Researchers have clearly identified which primary tumor source the metastatic foci belong to.
• •4. Those with mental illness or mental disorders, poor compliance and inability to cooperate and describe treatment responses;
• •5. Those with severe organic diseases or major organ failure, such as decompensated heart, lung, liver or kidney failure, which makes them unable to tolerate treatment;
• •6. Patients allergic to gosatetuzumab;
• •7. Patients who changed their treatment regimens after gosatetuzumab treatment due to non-disease progression reasons;
• •8. The researcher believes that the patient has other circumstances that make them unsuitable for participating in this study.